× Try our new beta.tvnews.vanderbilt.edu website, for new pricing, more content, and immediate delivery of loans.
Search the Archive

Health Watch (Breast Cancer) #397389

CBS Evening News for Thursday, Mar 29, 2001
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Dan Rather) The controversy over breast cancer treatment examined in light of statements from actress Suzanne Somers, who is being treated for cancer. [On "Larry King Live", SOMERS - describes her "alternative" treatment.] [In interview, medical consultant American Red Cross President Dr. Bernadine HEALY - describes Somers' "mistletoe" treatment {Iscador} as a poor alternative to chemotherapy; points out that Somers is a beloved celebrity who could lead people down the wrong path.]

Reporter(s):
Rather, Dan
Duration:
00:02:00

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.